Ibuprofen is used to relieve pain from various conditions such as headache, dental pain, menstrual cramps, muscle aches, or arthritis. It is also used to reduce fever and to relieve minor aches and pain due to the common cold or flu. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). Dexibuprofen is a pharmacologically effective enantiomer of racemic ibuprofen. Racemic ibuprofen and dexibuprofen differ in their physicochemical properties, and R(−) ibuprofen can exhibit pharmacological action only after conversion into dexibuprofen.
This report contains market size and forecasts of Ibuprofen Active Pharmaceutical Ingredient in global, including the following market information:
Global Ibuprofen Active Pharmaceutical Ingredient Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Ibuprofen Active Pharmaceutical Ingredient Market Sales, 2017-2022, 2023-2028, (Kiloton)
Global top five Ibuprofen Active Pharmaceutical Ingredient companies in 2021 (%)
The global Ibuprofen Active Pharmaceutical Ingredient market was valued at 662.6 million in 2021 and is projected to reach US$ 930.3 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Racemic Ibuprofen Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Ibuprofen Active Pharmaceutical Ingredient include SI Group, BASF SE, Solara Active Pharma Sciences Limit, IOL Chemicals And Pharmaceuticals Limited, Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd, Hubei Biocause Heilen Pharmaceutical Co., Ltd. and BIOCAUSE, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ibuprofen Active Pharmaceutical Ingredient manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ibuprofen Active Pharmaceutical Ingredient Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Ibuprofen Active Pharmaceutical Ingredient Market Segment Percentages, by Type, 2021 (%)
Racemic Ibuprofen
Dexibuprofen
Global Ibuprofen Active Pharmaceutical Ingredient Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Ibuprofen Active Pharmaceutical Ingredient Market Segment Percentages, by Application, 2021 (%)
Adult
Child
Global Ibuprofen Active Pharmaceutical Ingredient Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kiloton)
Global Ibuprofen Active Pharmaceutical Ingredient Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ibuprofen Active Pharmaceutical Ingredient revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Ibuprofen Active Pharmaceutical Ingredient revenues share in global market, 2021 (%)
Key companies Ibuprofen Active Pharmaceutical Ingredient sales in global market, 2017-2022 (Estimated), (Kiloton)
Key companies Ibuprofen Active Pharmaceutical Ingredient sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
SI Group
BASF SE
Solara Active Pharma Sciences Limit
IOL Chemicals And Pharmaceuticals Limited
Sino-US Zibo Xinhua-Perrigo Pharmaceutical Co., Ltd
Hubei Biocause Heilen Pharmaceutical Co., Ltd.
BIOCAUSE